ASSURE Trademark

Trademark Overview


On Monday, November 24, 2014, a trademark application was filed for ASSURE with the United States Patent and Trademark Office. The USPTO has given the ASSURE trademark a serial number of 86463776. The federal status of this trademark filing is REGISTERED as of Tuesday, July 16, 2019. This trademark is owned by Otsuka America Pharmaceutical, Inc.. The ASSURE trademark is filed in the Paper & Printed Material Products, Advertising, Business and Retail Services, Insurance & Financial Services, Education & Entertainment Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Educational services, namely, conducting educational programs and providing courses about central nervous system diseases, disorders and treatment; on-line publishing of electronic publications; on-line journals, namely, blogs about central nervous system diseases, disorders and treatment and vasopressin receptor antagonist responsive diseases, disorders, and treatment

Printed materials, namely, brochures, pamphlets and posters about patient support for central nervous system diseases, disorders and treatment and vasopressin receptor antagonist responsive diseases, disorders, and treatment

Providing financial information about reimbursement for medical expenses for patients with central nervous system diseases and disorders and vasopressin receptor antagonist responsive diseases and disorders; providing insurance information about medical benefit verification and prior authorization services for patients with central nervous system diseases and disorders and vasopressin receptor antagonist responsive diseases and disorders; providing insurance information about medical records coding, billing, and compliance for patients with central nervous system diseases and disorders and vasopressin receptor antagonist responsive diseases and disorders

Promoting awareness of patient support offerings for central nervous system diseases, disorders and treatment and vasopressin receptor antagonist responsive diseases, disorders, and treatment; discharge planning support, namely, providing consumer information to patients about health care plan options, products and programs in the field of managed care and state and federal medical care programs for central nervous system diseases, disorders and treatment and for vasopressin receptor antagonist responsive diseases, disorders, and treatment

Providing patient support in the nature of information about the location of medical treatment facilities for central nervous system diseases and disorders and for vasopressin receptor antagonist responsive diseases and disorders; providing medical information to medical professionals in the field of treatment of central nervous system diseases and disorders and of vasopressin receptor antagonist responsive diseases and disorders; providing a website for medical professionals featuring medical information in the field of treatment of central nervous system diseases and disorders and of vasopressin receptor antagonist responsive diseases and disorders
assure

General Information


Serial Number86463776
Word MarkASSURE
Filing DateMonday, November 24, 2014
Status700 - REGISTERED
Status DateTuesday, July 16, 2019
Registration Number5807079
Registration DateTuesday, July 16, 2019
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 31, 2017

Trademark Statements


Goods and ServicesEducational services, namely, conducting educational programs and providing courses about central nervous system diseases, disorders and treatment; on-line publishing of electronic publications; on-line journals, namely, blogs about central nervous system diseases, disorders and treatment and vasopressin receptor antagonist responsive diseases, disorders, and treatment
Description of MarkThe mark consists of a triangle composed of four geometric shapes, wherein three of the shapes are orange and one of the shapes is blue, adjacent to the wording "ASSURE" in gray stylized font. The color white is not claimed as a feature of the mark and represents background only.
Goods and ServicesPrinted materials, namely, brochures, pamphlets and posters about patient support for central nervous system diseases, disorders and treatment and vasopressin receptor antagonist responsive diseases, disorders, and treatment
Goods and ServicesProviding financial information about reimbursement for medical expenses for patients with central nervous system diseases and disorders and vasopressin receptor antagonist responsive diseases and disorders; providing insurance information about medical benefit verification and prior authorization services for patients with central nervous system diseases and disorders and vasopressin receptor antagonist responsive diseases and disorders; providing insurance information about medical records coding, billing, and compliance for patients with central nervous system diseases and disorders and vasopressin receptor antagonist responsive diseases and disorders
Indication of Colors claimedThe color(s) orange, blue, and gray is/are claimed as a feature of the mark.
Goods and ServicesPromoting awareness of patient support offerings for central nervous system diseases, disorders and treatment and vasopressin receptor antagonist responsive diseases, disorders, and treatment; discharge planning support, namely, providing consumer information to patients about health care plan options, products and programs in the field of managed care and state and federal medical care programs for central nervous system diseases, disorders and treatment and for vasopressin receptor antagonist responsive diseases, disorders, and treatment
Goods and ServicesProviding patient support in the nature of information about the location of medical treatment facilities for central nervous system diseases and disorders and for vasopressin receptor antagonist responsive diseases and disorders; providing medical information to medical professionals in the field of treatment of central nervous system diseases and disorders and of vasopressin receptor antagonist responsive diseases and disorders; providing a website for medical professionals featuring medical information in the field of treatment of central nervous system diseases and disorders and of vasopressin receptor antagonist responsive diseases and disorders

Classification Information


International Class016 - Paper, cardboard and goods made from these materials, not included in other classes; printed matter; bookbinding material; photographs; stationery; adhesives for stationery or household purposes; artists' materials; paint brushes; typewriters and office requisites (except furniture); instructional and teaching material (except apparatus); plastic materials for packaging (not included in other classes); printers' type; printing blocks.
US Class Codes002, 005, 022, 023, 029, 037, 038, 050
Class Status Code6 - Active
Class Status DateWednesday, December 3, 2014
Primary Code016
First Use Anywhere DateMonday, November 24, 2014
First Use In Commerce DateMonday, November 24, 2014

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, December 3, 2014
Primary Code035
First Use Anywhere DateMonday, November 24, 2014
First Use In Commerce DateMonday, November 24, 2014

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, September 17, 2015
Primary Code036
First Use Anywhere DateMonday, November 24, 2014
First Use In Commerce DateMonday, November 24, 2014

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateWednesday, December 3, 2014
Primary Code041
First Use Anywhere DateMonday, November 24, 2014
First Use In Commerce DateMonday, November 24, 2014

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, December 3, 2014
Primary Code044
First Use Anywhere DateMonday, November 24, 2014
First Use In Commerce DateMonday, November 24, 2014

Trademark Owner History


Party NameOtsuka America Pharmaceutical, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Party NameOtsuka America Pharmaceutical, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Party NameOtsuka America Pharmaceutical, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Trademark Events


Event DateEvent Description
Thursday, March 12, 2015ASSIGNED TO EXAMINER
Thursday, November 27, 2014NEW APPLICATION ENTERED
Wednesday, December 3, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 4, 2014NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, March 19, 2015NON-FINAL ACTION WRITTEN
Thursday, March 19, 2015NON-FINAL ACTION E-MAILED
Thursday, March 19, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 16, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 16, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 17, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 20, 2016ASSIGNED TO LIE
Thursday, October 1, 2015SUSPENSION LETTER WRITTEN
Thursday, October 1, 2015LETTER OF SUSPENSION E-MAILED
Thursday, October 1, 2015NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, April 27, 2016SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, May 18, 2016NON-FINAL ACTION WRITTEN
Wednesday, May 18, 2016NON-FINAL ACTION E-MAILED
Wednesday, May 18, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, November 18, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 18, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, November 19, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 11, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, December 10, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, December 24, 2016ASSIGNED TO LIE
Wednesday, December 28, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, January 31, 2017PUBLISHED FOR OPPOSITION
Tuesday, January 31, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 28, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, September 27, 2017SOU TEAS EXTENSION RECEIVED
Wednesday, September 27, 2017SOU EXTENSION 1 FILED
Wednesday, September 27, 2017SOU EXTENSION 1 GRANTED
Friday, September 29, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 8, 2017TEAS STATEMENT OF USE RECEIVED
Wednesday, November 8, 2017USE AMENDMENT FILED
Monday, November 20, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 27, 2017ITU OFFICE ACTION ISSUED FOR STATEMENT OF USE
Friday, December 1, 2017RESPONSE TO ITU OFFICE ACTION ENTERED
Friday, December 1, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 8, 2017STATEMENT OF USE PROCESSING COMPLETE
Friday, December 29, 2017SU - NON-FINAL ACTION - WRITTEN
Friday, December 29, 2017NON-FINAL ACTION E-MAILED
Friday, December 29, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 27, 2018SOU TEAS EXTENSION RECEIVED
Friday, June 29, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 5, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 5, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 27, 2018SU - FINAL REFUSAL - WRITTEN
Friday, July 27, 2018FINAL REFUSAL E-MAILED
Friday, July 27, 2018NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, January 28, 2019TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, January 28, 2019EXPARTE APPEAL RECEIVED AT TTAB
Monday, January 28, 2019JURISDICTION RESTORED TO EXAMINING ATTORNEY
Monday, January 28, 2019EX PARTE APPEAL-INSTITUTED
Thursday, January 31, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 31, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 20, 2019SU - ACTION CONTINUING FINAL - WRITTEN
Wednesday, February 20, 2019CONTINUATION OF FINAL REFUSAL E-MAILED
Wednesday, February 20, 2019NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Monday, February 25, 2019TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, March 4, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 4, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 25, 2019SU - ACTION CONTINUING FINAL - WRITTEN
Monday, March 25, 2019ACTION DENYING REQ FOR RECON E-MAILED
Monday, March 25, 2019NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Friday, May 17, 2019JURISDICTION RESTORED TO EXAMINING ATTORNEY
Sunday, June 9, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, June 11, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, July 8, 2019ASSIGNED TO EXAMINER
Tuesday, July 16, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, July 16, 2019EXPARTE APPEAL TERMINATED
Tuesday, July 16, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED